Enzymotec Signs Krill Deal with India Pharma Company

April 22, 2011

Enzymotec Ltd. has signed a long term deal to supply krill oil to Lupin Ltd. (Mumbai, India), a leading pharmaceutical company focusing on non-steroidal anti-inflammatory drugs, bacterial infections, and cardiovascular disease.

Enzymotec Ltd. (Migdal HaEmek, Israel) has signed a long term deal to supply krill oil to Lupin Ltd. (Mumbai, India), a leading pharmaceutical company focusing on non-steroidal anti-inflammatory drugs, bacterial infections, and cardiovascular disease.

Lupin is the world’s fifth largest pharmaceutical company, based on subscriptions, says Enzymotec.

A Krill Oil+ product will launch later this year in Indian markets.